Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Moldvay

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|July 29, 2023
Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral HeterogeneityBeáta Szeitz, Tibor Glasz, Zoltán Herold, et al.
Biomedicines|December 23, 2023
Application of a Receptor-Binding-Domain-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus VariantsOrsolya Mózner, Judit Moldvay, Kata Sára Szabó, et al.
Pathology Oncology Research : POR|October 11, 2021
Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary TumorPeter Radeczky, Judit Moldvay, Janos Fillinger, et al.
Magyar Onkologia|June 3, 2021
[Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy]Péter Radeczky, Zsolt Megyesfalvi, János Fillinger, et al.
Acta Oncologica (Stockholm, Sweden)|April 20, 2019
Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinomaLilla Reiniger, Vanda Téglási, Orsolya Pipek, et al.
Thoracic Cancer|February 3, 2021
The landscape of small cell lung cancer metastases: Organ specificity and timingZsolt Megyesfalvi, Bernadett Tallosy, Orsolya Pipek, et al.
Clinical Lung Cancer|June 11, 2019
PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain MetastasisVanda Téglási, Orsolya Pipek, Rita Lózsa, et al.
NPJ Precision Oncology|June 19, 2021
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signaturesMiklos Diossy, Zsofia Sztupinszki, Judit Borcsok, et al.
Neuro-Oncology|February 16, 2017
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasisVanda Téglási, Lilla Reiniger, Katalin Fábián, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinomaOz Kilim, Orsolya Pipek, Zsofia Sztupinszki, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|July 29, 2023
Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral HeterogeneityBeáta Szeitz, Tibor Glasz, Zoltán Herold, et al.
Biomedicines|December 23, 2023
Application of a Receptor-Binding-Domain-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus VariantsOrsolya Mózner, Judit Moldvay, Kata Sára Szabó, et al.
Pathology Oncology Research : POR|October 11, 2021
Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary TumorPeter Radeczky, Judit Moldvay, Janos Fillinger, et al.
Magyar Onkologia|June 3, 2021
[Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy]Péter Radeczky, Zsolt Megyesfalvi, János Fillinger, et al.
Acta Oncologica (Stockholm, Sweden)|April 20, 2019
Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinomaLilla Reiniger, Vanda Téglási, Orsolya Pipek, et al.
Thoracic Cancer|February 3, 2021
The landscape of small cell lung cancer metastases: Organ specificity and timingZsolt Megyesfalvi, Bernadett Tallosy, Orsolya Pipek, et al.
Clinical Lung Cancer|June 11, 2019
PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain MetastasisVanda Téglási, Orsolya Pipek, Rita Lózsa, et al.
NPJ Precision Oncology|June 19, 2021
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signaturesMiklos Diossy, Zsofia Sztupinszki, Judit Borcsok, et al.
Neuro-Oncology|February 16, 2017
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasisVanda Téglási, Lilla Reiniger, Katalin Fábián, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinomaOz Kilim, Orsolya Pipek, Zsofia Sztupinszki, et al.
Pageof 11